A 50-year-old woman with a month of continuous menstrual‑type vaginal bleeding; what is the appropriate evaluation and management?

Evaluation and Management of Prolonged Vaginal Bleeding in a 50-Year-Old Woman

A 50-year-old woman with continuous bleeding for one month requires urgent evaluation to exclude endometrial cancer and other structural pathology, starting with transvaginal ultrasound to measure endometrial thickness and endometrial biopsy if indicated by risk factors.

Immediate Evaluation Priority

At age 50, this patient is perimenopausal and at increased risk for endometrial pathology. The evaluation must systematically exclude malignancy before attributing bleeding to benign perimenopausal changes.

Essential History Elements

• Bleeding pattern specifics: Volume (clots ≥1 inch suggest heavy bleeding), frequency of pad/tampon changes (hourly = "flooding"), duration of flow 1
• Risk factors for endometrial cancer: Obesity, diabetes, hypertension, unopposed estrogen exposure, tamoxifen use, family history of Lynch syndrome or endometrial/colorectal cancer 2
• Personal/family bleeding history: Suggests underlying coagulopathy if present 1
• Medication review: Anticoagulants, hormonal contraceptives, antipsychotics, antiepileptics 3
• Contraceptive use: Particularly DMPA or other hormonal methods 4

Physical Examination

• Speculum examination: Identify cervical lesions, polyps, atrophic changes, or obvious bleeding source 5
• Pelvic examination: Assess for uterine enlargement, masses, tenderness 3

Diagnostic Algorithm

First-Line Testing

Laboratory:

• Pregnancy test (β-hCG) - mandatory regardless of age 3
• Complete blood count to assess for anemia 6
• TSH and prolactin if anovulation suspected 3
• Consider coagulation studies if personal/family bleeding history present 1

Imaging:

• Transvaginal ultrasound is the first-line imaging modality 6
• Measures endometrial thickness (critical threshold: <5mm in postmenopausal women suggests low cancer risk) 5
• Identifies structural abnormalities: fibroids, polyps, adenomyosis 7

Indications for Endometrial Biopsy

Mandatory biopsy if:

• Age ≥35 years with recurrent anovulation 3
• Any age with risk factors for endometrial cancer 3
• Excessive bleeding unresponsive to medical therapy 3
• Endometrial thickness concerning on ultrasound 5

Important caveat: Endometrial biopsy has a 10% false-negative rate. If bleeding persists despite negative biopsy, proceed to fractional D&C under anesthesia 2.

Second-Line Procedures (if ultrasound inadequate or biopsy negative with persistent symptoms)

• Saline infusion sonohysterography (96-100% sensitivity for intracavitary pathology) 8
• Hysteroscopy for direct visualization 2
• MRI if ultrasound cannot adequately visualize endometrium due to fibroids or adenomyosis 7

Management Based on Findings

If Structural Pathology Identified

• Endometrial hyperplasia without atypia: Cyclic or continuous progestin therapy 3
• Hyperplasia with atypia or cancer: Urgent referral to gynecologic oncologist 2, 3
• Polyps or submucosal fibroids: Consider polypectomy, fibroidectomy, or uterine artery embolization 3

If No Structural Pathology (Functional Bleeding)

This represents perimenopausal anovulatory bleeding, which is common but requires treatment if heavy or persistent beyond 3 months 9.

Medical Management Options (ranked by efficacy):

1. Levonorgestrel-releasing IUD - Most effective for heavy menstrual bleeding 6, 10

2. Tranexamic acid - Particularly useful when hormones contraindicated or immediate pregnancy desired 6, 10

3. Combined oral contraceptives - Regulate cycles and reduce bleeding 3, 10

4. Oral progestins - 21 days per month for cycle regulation 3, 6

5. NSAIDs - Reduce menstrual blood loss, can be combined with hormonal methods 10

Acute Heavy Bleeding Management

If presenting with acute heavy bleeding:

• Multidose combined oral contraceptive regimen (monophasic pill three times daily until bleeding stops, then taper) 10
• Parenteral estrogen in hospital setting 10
• Tranexamic acid 1300mg three times daily during bleeding 10

Critical Pitfalls to Avoid

1. Do not assume perimenopausal bleeding is benign - Endometrial cancer occurs in approximately 10% of women with postmenopausal bleeding and risk increases with age 5

2. Do not rely solely on negative endometrial biopsy - 10% false-negative rate requires clinical follow-up 2

3. Do not perform digital pelvic exam before imaging if pregnancy possible - Could disrupt placenta previa (though less relevant at age 50) 11

4. Do not attribute bleeding to contraceptive side effects without excluding pathology first - While DMPA and other methods cause irregular bleeding 4, structural causes must be ruled out in this age group

5. Do not delay evaluation - One month of continuous bleeding at age 50 warrants urgent assessment, not expectant management 5

Special Considerations

If patient is on DMPA or other hormonal contraception: While bleeding irregularities are common with these methods 4, 12, at age 50 with one month of continuous bleeding, underlying pathology must still be excluded before attributing symptoms to the contraceptive method.

Lynch syndrome screening: Consider if family history of endometrial or colorectal cancer, especially if patient <50 years 2